# The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney Disease

> **NCT01165567** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Boramae Hospital** · enrollment: 212 (estimated)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** sarpogrelate

## Key facts

- **NCT ID:** NCT01165567
- **Lead sponsor:** Seoul National University Boramae Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2010-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01165567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01165567, "The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01165567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*